Novel bispecific antibodies show promise against evolving SARS-CoV-2 variants Researchers developed bispecific antibodies targeting both the N-terminal and receptor binding domains of SARS-CoV-2, demonstrating significant neutralization across various Omicron variants, suggesti...

Novel bispecific antibodies show promise against evolving SARS-CoV-2 variants 🦠🧬💉 www.news-medical.net/news/2024050... #COVID19Research #Bispecific #Antibodies #Omicron #Variants #Vaccine #AntibodyTherapy #Pandemic #ViralNeutralization #SARSCoV2 @biorxivpreprint.bsky.social